Herpangina
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- A viral infectious disease that results in infection located in mouth, has material basis in Human coxsackievirus A16, has material basis in Human enterovirus 71, has material basis in group B coxsackievirus, or has material basis in echoviruses, which are transmitted by ingestion of food contaminated with feces, transmitted by contact with pharyngeal secretions, or transmitted by droplet spread of oronasal secretions. The infection has symptom fever, has symptom sore throat, and has symptom lesions in the back area of the mouth, particularly the soft palate or tonsillar pillars.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Herpangina
- Alternative names
- herpangina
- Therapeutic area
- Infectious Disease
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Mild
- MONDO ID
- MONDO:0005791
- Parent condition
- MONDO:0005108
Related records
Broader conditions (6)
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
- Viral infectious disease
Trials (8)
- A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months
- Effect of Recombinant Human Interferon α-2b Spray on Herpangina
- Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
- Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam
- Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
- Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial
- Surveillance of HFMD in Pediatric Outpatients
- Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).